NCT07736573

Brief Summary

This study evaluated the feasibility, safety, and preliminary functional outcomes of invasive vagus nerve stimulation (iVNS) paired with upper-limb rehabilitation in participants with chronic stroke-related upper-limb motor dysfunction. Participants received cervical iVNS implantation followed by a 6-week supervised rehabilitation program and subsequent home-based rehabilitation. Changes in upper-limb motor function, spasticity, quality of life, and safety outcomes were assessed. Exploratory neuroimaging assessments using positron emission tomography/computed tomography and arterial spin labeling were performed in selected participants to evaluate changes in brain metabolism and perfusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 30, 2026

Completed
Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

11 months

First QC Date

July 26, 2026

Last Update Submit

July 26, 2026

Conditions

Keywords

upper limb rehabilitationinvasive vagus nerve stimulationintracerebral hemorrhageneuromodulation

Outcome Measures

Primary Outcomes (1)

  • Change in Fugl-Meyer Assessment Upper Extremity (FMA-UE) Score

    Change in upper-limb motor function assessed by the Fugl-Meyer Assessment Upper Extremity score from baseline after invasive vagus nerve stimulation paired rehabilitation.

    6 weeks after initiation of rehabilitation

Interventions

Participants received left cervical invasive vagus nerve stimulation using an implanted pulse generator and electrode system, combined with structured upper-limb rehabilitation. Stimulation parameters were adjusted according to individual tolerance. Rehabilitation included supervised in-clinic training followed by home-based rehabilitation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants with chronic stroke-related upper-limb motor dysfunction who underwent invasive vagus nerve stimulation paired with rehabilitation at Beijing Chao-Yang Hospital, Capital Medical University.

You may qualify if:

  • Adults aged 18 years or older.
  • Documented history of stroke with persistent upper-limb motor dysfunction.
  • Completion of invasive vagus nerve stimulation implantation.
  • Completion of paired upper-limb rehabilitation after stimulation.
  • Availability of clinical assessments during follow-up.

You may not qualify if:

  • Other central nervous system disorders affecting motor function assessment.
  • Severe disturbance of consciousness or inability to complete standardized functional assessments.
  • Severe cognitive, communication, musculoskeletal, or peripheral nerve disorders interfering with upper-limb function evaluation.
  • Missing key clinical or follow-up data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Chao-Yang Hospital, Capital Medical University

Beijing, Beijing Municipality, 100020, China

Location

MeSH Terms

Conditions

StrokeCerebral Hemorrhage

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesIntracranial HemorrhagesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2026

First Posted

July 30, 2026

Study Start

January 10, 2025

Primary Completion

December 15, 2025

Study Completion

March 15, 2026

Last Updated

July 30, 2026

Record last verified: 2026-07

Locations